JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB275507

Human TNF knockout THP-1 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TNF KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 52 bp deletion in exon 4.
4 Images
Western blot - Human TNF knockout THP-1 cell lysate (AB275507)
  • WB

Lab

Western blot - Human TNF knockout THP-1 cell lysate (AB275507)

Lane 1 : Wild-type THP-1 Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 2 : Wild-type THP-1 LPS treated (100 ng/ml, 16 h) and Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 3 : TNF alpha knockout THP-1 Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 4 : TNF alpha knockout THP-1 LPS treated (100 ng/ml, 16 h) and Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 5 : U937 PMA treated (10 mM, 2 days) plus 16 h no treatment and Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 6 : U937 PMA treated (10 mM, 2 days) and LPS treated (1 ug/ml, 16 h) plus Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lanes 1 - 6 : Merged signal (red and green). Green - ab255275 observed at 26 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55kDa.
ab255275 was shown to react with TNF alpha in wild-type THP-1 cells in Western blot with loss of signal observed in TNF knockout sample. Wild-type and TNF knockout THP-1 cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab255275 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-TNF alpha antibody [EPR22598-212] (<a href='/en-us/products/primary-antibodies/tnf-alpha-antibody-epr22598-212-ab255275'>ab255275</a>) at 1/1000 dilution

Lane 1:

Wild-type THP-1 Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 2:

Wild-type THP-1 LPS treated (100 ng/ml, 16 h) and Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 2:

Western blot - Human TNF knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-tnf-knockout-thp-1-cell-line-ab273761'>ab273761</a>)

Lane 3:

TNF alpha knockout THP-1 Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 4:

TNF alpha knockout THP-1 LPS treated (100 ng/ml, 16 h) and Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 5:

U937 PMA treated (10 mM, 2 days) plus 16 h no treatment and Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 6:

U937 PMA treated (10 mM, 2 days) and LPS treated (1 µg/ml, 16 h) plus Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Predicted band size: 25 kDa

Observed band size: 26 kDa

false

Western blot - Human TNF knockout THP-1 cell lysate (AB275507)
  • WB

Lab

Western blot - Human TNF knockout THP-1 cell lysate (AB275507)

Lane 1 : Wild-type THP-1 control : Brefeldin A (5 μg/mL, 4 h) cell lysate 30 μg
Lane 2 : Wild-type treated THP-1 : LPS (100 ng/mL, 16 h), Brefeldin A (5 μg/mL, last 4 h) cell lysate 30 μg
Lane 3 : TNF alpha knockout THP-1 control : Brefeldin A (5 μg/mL, 4 h) cell lysate 30 μg
Lane 4 : TNF alpha knockout THP-1 treated : LPS (100 ng/mL, 16 h), Brefeldin A (5 μg/mL, last 4 h) cell lysate 30 μg
Lane 5 : U937 control : PMA (10 mM, 2 days), Brefeldin A (5 μg/mL, last 4 h) cell lysate 30 μg
Lane 6 : U937 treated : PMA (10 mM, 2 days), LPS (1 μg/mL, last 16 h), Brefeldin A (5 μg/mL, last 4 h) cell lysate 30 μg
This Western blot image is a comparison between ab215188 and ab183218 tested under the same conditions. While ab215188 is suitable for WB for some samples, ab183218 was found to be more sensitive.False colour image of Western blot : Anti-TNF alpha antibody [EPR20972] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab215188 was shown to bind specifically to TNF alpha. A band was observed at 27 kDa in treated U937 cell lysates with no signal observed at this size without treatment. No signal was observed in wild-type THP-1 cell lysates or in TNF knockout cell line ab273761 (knockout cell lysate ab275507) with ab215188. However, a band was observed at 27 kDa in treated wild-type THP-1 cell lysates with ab183218. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-TNF alpha antibody [EPR20972] (<a href='/en-us/products/primary-antibodies/tnf-alpha-antibody-epr20972-ab215188'>ab215188</a>) at 1/1000 dilution

Lane 1:

Wild-type THP-1 control: Brefeldin A (5 ug/mL, 4 h) cell lysate at 30 µg

Lane 2:

Wild-type treated THP-1: LPS (100 ng/mL, 16 h), Brefeldin A (5 ug/mL, last 4 h) cell lysate at 30 µg

Lane 2:

Western blot - Human TNF knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-tnf-knockout-thp-1-cell-line-ab273761'>ab273761</a>)

Lane 3:

TNF alpha knockout THP-1 control: Brefeldin A (5 ug/mL, 4 h) cell lysate at 30 µg

Lane 4:

TNF alpha knockout THP-1 treated: LPS (100 ng/mL, 16 h), Brefeldin A (5 ug/mL, last 4 h) cell lysate at 30 µg

Lane 5:

U937 control: PMA (10 mM, 2 days), Brefeldin A (5 ug/mL, last 4 h) cell lysate at 30 µg

Lane 6:

U937 treated: PMA (10 mM, 2 days), LPS (1 ug/mL, last 16 h), Brefeldin A (5 ug/mL, last 4 h) cell lysate at 30 µg

Predicted band size: 25 kDa

Observed band size: 27 kDa

false

Western blot - Human TNF knockout THP-1 cell lysate (AB275507)
  • WB

Lab

Western blot - Human TNF knockout THP-1 cell lysate (AB275507)

Lane 1 : Wild-type THP-1 Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 2 : Wild-type THP-1 LPS treated (100 ng/ml, 16 h) and Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 3 : TNF alpha knockout THP-1 Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 4 : TNF alpha knockout THP-1 LPS treated (100 ng/ml, 16 h) and Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 5 : U937 PMA treated (10 mM, 2 days) plus 16 h no treatment and Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lane 6 : U937 PMA treated (10 mM, 2 days) and LPS treated (1 ug/ml, 16 h) plus Brefeldin A (ab120299) treated (5 ug/ml, 4 h) cell lysate 30 ug
Lanes 1 - 6 : Merged signal (red and green). Green - ab183218 observed at 26 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55kDa.
ab183218 was shown to react with TNF alpha in wild-type THP-1 cells in Western blot with loss of signal observed in TNF knockout sample. Wild-type and TNF knockout THP-1 cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab183218 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-TNF alpha antibody [EPR19147] (<a href='/en-us/products/primary-antibodies/tnf-alpha-antibody-epr19147-ab183218'>ab183218</a>) at 1/1000 dilution

Lane 1:

Wild-type THP-1 Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 2:

Wild-type THP-1 LPS treated (100 ng/ml, 16 h) and Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 2:

Western blot - Human TNF knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-tnf-knockout-thp-1-cell-line-ab273761'>ab273761</a>)

Lane 3:

TNF alpha knockout THP-1 Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 4:

TNF alpha knockout THP-1 LPS treated (100 ng/ml, 16 h) and Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 5:

U937 PMA treated (10 mM, 2 days) plus 16 h no treatment and Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Lane 6:

U937 PMA treated (10 mM, 2 days) and LPS treated (1 µg/ml, 16 h) plus Brefeldin A (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) treated (5 µg/ml, 4 h) cell lysate at 30 µg

Predicted band size: 25 kDa

Observed band size: 26 kDa

false

Sanger Sequencing - Human TNF knockout THP-1 cell lysate (AB275507)
  • Sanger seq

Supplier Data

Sanger Sequencing - Human TNF knockout THP-1 cell lysate (AB275507)

Homozygous : 52 bp deletion in exon 4

Key facts

Cell type

THP-1

Species or organism

Human

Tissue

Blood

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 52 bp deletion in exon 4

Disease

Acute Monocytic Leukemia

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

Treatments:
Human TNF knockout THP-1 cell lysate - Brefeldin A (5 μg/ml, 6h)
Human wild-type THP-1 cell lysate - Brefeldin A (5 μg/ml, 6h)
Human TNF knockout THP-1 cell lysate - LPS (1 μg/ml, 16h) and Brefeldin A (5 μg/ml, during the last 6h of LPS treatment)
Human wild-type THP-1 cell lysate - LPS (1 μg/ml, 16h) and Brefeldin A (5 μg/ml, during the last 6h of LPS treatment)

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab275507-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TNF knockout THP-1 cell lysate - Brefeldin A treated", "number":"AB275507-CMP03", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type THP-1 cell lysate - LPS + Brefeldin A treated", "number":"AB275507-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human TNF knockout THP-1 cell lysate - LPS + Brefeldin A treated", "number":"AB275507-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type THP-1 cell lysate - Brefeldin A treated", "number":"AB275507-CMP04", "productcode":"" } ] } } }

Properties and storage information

Gene name
TNF
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Suspension

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com